Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatology | 3 | 2021 | 127 | 0.920 |
Why?
|
| Murine hepatitis virus | 1 | 2024 | 16 | 0.880 |
Why?
|
| Endoribonucleases | 1 | 2024 | 81 | 0.850 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2024 | 110 | 0.840 |
Why?
|
| Panniculitis | 1 | 2021 | 3 | 0.710 |
Why?
|
| Alveolar Epithelial Cells | 5 | 2025 | 114 | 0.680 |
Why?
|
| Homeostasis | 1 | 2024 | 621 | 0.670 |
Why?
|
| Vascular Malformations | 2 | 2018 | 52 | 0.650 |
Why?
|
| Glomus Tumor | 1 | 2017 | 2 | 0.550 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2017 | 7 | 0.550 |
Why?
|
| Lasers, Solid-State | 1 | 2017 | 22 | 0.540 |
Why?
|
| Cryopyrin-Associated Periodic Syndromes | 1 | 2016 | 6 | 0.530 |
Why?
|
| Psoriasis | 1 | 2016 | 102 | 0.490 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 151 | 0.480 |
Why?
|
| Telemedicine | 2 | 2021 | 862 | 0.480 |
Why?
|
| Laser Therapy | 1 | 2017 | 130 | 0.480 |
Why?
|
| Inflammasomes | 1 | 2016 | 131 | 0.470 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 3 | 2025 | 657 | 0.390 |
Why?
|
| eIF-2 Kinase | 1 | 2024 | 31 | 0.220 |
Why?
|
| Unfolded Protein Response | 1 | 2024 | 59 | 0.220 |
Why?
|
| Dinoprost | 1 | 2023 | 44 | 0.210 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2025 | 197 | 0.210 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2025 | 248 | 0.210 |
Why?
|
| Pulmonary Surfactants | 1 | 2024 | 106 | 0.210 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2023 | 45 | 0.200 |
Why?
|
| Betacoronavirus | 1 | 2024 | 270 | 0.180 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 318 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2021 | 137 | 0.170 |
Why?
|
| Abdomen | 1 | 2021 | 125 | 0.170 |
Why?
|
| Mice | 7 | 2025 | 17787 | 0.160 |
Why?
|
| Mutation, Missense | 1 | 2021 | 341 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2024 | 364 | 0.150 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 89 | 0.150 |
Why?
|
| Skin Diseases | 1 | 2020 | 149 | 0.150 |
Why?
|
| Autophagy | 1 | 2021 | 284 | 0.150 |
Why?
|
| Neutrophils | 1 | 2024 | 1238 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2024 | 481 | 0.150 |
Why?
|
| Mutation | 3 | 2023 | 3958 | 0.150 |
Why?
|
| Irritants | 1 | 2018 | 43 | 0.150 |
Why?
|
| Lung Injury | 1 | 2021 | 219 | 0.150 |
Why?
|
| Dermatitis, Atopic | 1 | 2022 | 329 | 0.150 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2018 | 75 | 0.140 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2018 | 73 | 0.140 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 232 | 0.140 |
Why?
|
| Waiting Lists | 1 | 2019 | 266 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4295 | 0.130 |
Why?
|
| ras Proteins | 1 | 2018 | 153 | 0.130 |
Why?
|
| Sweet Syndrome | 1 | 2016 | 8 | 0.130 |
Why?
|
| Acne Vulgaris | 1 | 2016 | 29 | 0.130 |
Why?
|
| Lung | 3 | 2024 | 4060 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 804 | 0.130 |
Why?
|
| Eczema | 1 | 2016 | 69 | 0.120 |
Why?
|
| Humans | 13 | 2025 | 137585 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 320 | 0.120 |
Why?
|
| Animals | 8 | 2025 | 36940 | 0.120 |
Why?
|
| Pain | 1 | 2021 | 756 | 0.120 |
Why?
|
| Alleles | 1 | 2018 | 891 | 0.110 |
Why?
|
| Child | 5 | 2021 | 21935 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2021 | 15657 | 0.100 |
Why?
|
| Adolescent | 4 | 2021 | 21513 | 0.100 |
Why?
|
| Pandemics | 1 | 2021 | 1639 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2607 | 0.090 |
Why?
|
| Pediatrics | 1 | 2019 | 1101 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2016 | 828 | 0.090 |
Why?
|
| Infant | 3 | 2022 | 9465 | 0.080 |
Why?
|
| Phenotype | 1 | 2018 | 3196 | 0.080 |
Why?
|
| Male | 5 | 2022 | 67762 | 0.070 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2024 | 12 | 0.060 |
Why?
|
| Nanomedicine | 1 | 2024 | 47 | 0.050 |
Why?
|
| Endothelium | 1 | 2024 | 123 | 0.050 |
Why?
|
| Glycolysis | 1 | 2025 | 321 | 0.050 |
Why?
|
| Population Dynamics | 1 | 2023 | 151 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2017 | 11074 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2022 | 216 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 552 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 298 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 307 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 106 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2023 | 405 | 0.040 |
Why?
|
| Philadelphia | 1 | 2019 | 49 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 948 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 996 | 0.040 |
Why?
|
| Play and Playthings | 1 | 2018 | 33 | 0.040 |
Why?
|
| Female | 4 | 2020 | 73304 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 1 | 2021 | 402 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 107 | 0.030 |
Why?
|
| Transcriptome | 1 | 2023 | 971 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 956 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 512 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1007 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 730 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2757 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1710 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 2828 | 0.030 |
Why?
|
| Skin | 1 | 2018 | 752 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 5757 | 0.030 |
Why?
|
| Zebrafish | 1 | 2018 | 499 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 5079 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 986 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 5742 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 7604 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 10811 | 0.020 |
Why?
|
| Adult | 1 | 2018 | 37929 | 0.010 |
Why?
|